CA2545484A1 - Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin - Google Patents

Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin Download PDF

Info

Publication number
CA2545484A1
CA2545484A1 CA002545484A CA2545484A CA2545484A1 CA 2545484 A1 CA2545484 A1 CA 2545484A1 CA 002545484 A CA002545484 A CA 002545484A CA 2545484 A CA2545484 A CA 2545484A CA 2545484 A1 CA2545484 A1 CA 2545484A1
Authority
CA
Canada
Prior art keywords
groups
chain alkyl
group
alkyl substituted
substituted amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002545484A
Other languages
English (en)
French (fr)
Inventor
Rudolf Moser
Viola Groehn
Andreas Schumacher
Pierre Martin
Dirk Spielvogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomarin Pharmaceutical Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2545484A1 publication Critical patent/CA2545484A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002545484A 2003-11-17 2004-11-17 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin Abandoned CA2545484A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52036803P 2003-11-17 2003-11-17
US52036703P 2003-11-17 2003-11-17
US60/520,367 2003-11-17
US60/520,368 2003-11-17
PCT/US2004/038313 WO2005049614A2 (en) 2003-11-17 2004-11-17 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin

Publications (1)

Publication Number Publication Date
CA2545484A1 true CA2545484A1 (en) 2005-06-02

Family

ID=34623128

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002545484A Abandoned CA2545484A1 (en) 2003-11-17 2004-11-17 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin

Country Status (6)

Country Link
US (1) US7732599B2 (https=)
EP (1) EP1776364A2 (https=)
JP (1) JP5184783B2 (https=)
AU (1) AU2004290692A1 (https=)
CA (1) CA2545484A1 (https=)
WO (1) WO2005049614A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
KR20070084270A (ko) 2004-11-17 2007-08-24 바이오마린 파머수티컬 인크. 안정한 정제 제형물
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
LT2545939T (lt) 2007-04-11 2021-03-10 Biomarin Pharmaceutical Inc. Tetrahidrobiopterinas, skirtas gydyti ligas, susijusias supadidėjusiu fenilalanino kiekiu
RU2470642C2 (ru) * 2008-01-03 2012-12-27 Байомарин Фармасьютикл Инк. Аналоги птерина для лечения состояния, чувствительного к вн4
BRPI0907247A2 (pt) 2008-01-07 2015-07-14 Biomarin Pharm Inc Métodos para preparar biopterina e para preparar tetraidrobiopterina
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN102633799B (zh) * 2012-04-10 2014-06-25 凯莱英医药集团(天津)股份有限公司 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
CN104736539B (zh) 2012-05-07 2017-09-01 白鸟制药株式会社 墨蝶呤和四氢乳酰蝶呤的制造法
WO2016189542A1 (en) 2015-05-28 2016-12-01 Natco Pharma Ltd Novel process for the preparation of sapropterin dihydrochloride and its key intermediate, l-biopterin
IL305149A (en) 2016-07-26 2023-10-01 Biomarin Pharm Inc Novel adeno-associated virus capsid proteins
MA46973A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Polymorphes de sépiaptérine et leurs sels
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
JP7811085B2 (ja) 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
TW202016314A (zh) 2018-05-09 2020-05-01 美商拜奧馬林製藥公司 治療苯丙酮尿症之方法
TW202005978A (zh) 2018-05-14 2020-02-01 美商拜奧馬林製藥公司 新穎肝靶向腺相關病毒載體
FI3801536T3 (fi) 2018-05-30 2024-08-29 Ptc Therapeutics Mp Inc Sepiapteriinin antaminen ilman ruokaa käytettäväksi menetelmässä sepiapteriinin plasma-altistuksen lisäämiseksi
EP3801534B1 (en) 2018-05-30 2026-02-18 PTC Therapeutics MP, Inc. Treatment of phenylketonuria with sepiapterin
TW202144575A (zh) 2020-04-03 2021-12-01 美商拜奧馬林製藥公司 使用aav及治療調配物之苯酮尿症治療
GB202307239D0 (en) 2023-05-15 2023-06-28 Evox Therapeutics Ltd Gene therapies for Phenylketonuria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617287A (ja) 1984-06-21 1986-01-13 Kanegafuchi Chem Ind Co Ltd 5‐デオキシ‐l‐アラビノースの製造法
JP2575781B2 (ja) * 1988-02-29 1997-01-29 日清製粉株式会社 2,3−ジアシルオキシ−4−ヒドロキシ−トペンタナールおよびその製造方法

Also Published As

Publication number Publication date
JP5184783B2 (ja) 2013-04-17
WO2005049614A3 (en) 2007-03-08
EP1776364A2 (en) 2007-04-25
JP2007534637A (ja) 2007-11-29
US20070244322A1 (en) 2007-10-18
WO2005049614A2 (en) 2005-06-02
US7732599B2 (en) 2010-06-08
AU2004290692A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
US7732599B2 (en) Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin
TWI496781B (zh) 製備{4,6-二胺基-2-[1-(2-氟苯甲基)-1H-吡唑并[3,4-b]吡啶-3-基]嘧啶-5-基}甲基胺基甲酸甲酯之方法及其使用作為醫藥活性化合物之純化
ES2923278T3 (es) Intermedios útiles para la síntesis de derivados de aminopirimidinas, proceso de preparación del mismo y proceso de preparación de aminopirimidina derivados utilizando los mismos
EP3882236B1 (en) Production method for 2,5-dicyano-3,6-dihalogenopyrazine
CN101657462A (zh) 卡培他滨的制备方法及其中间体
RS64654B1 (sr) Proces za pripremu n-(5-((4-(4-((dimetilamino)metil)-3-fenil-1h-pirazol-1-il)pirimidin-2-il)amino)-4-metoksi-2- morfolinofenil)akrilamida reakcijom odgovarajućeg amina sa 3-halo-propionil hloridom
UA125595C2 (uk) Проміжні сполуки, корисні для синтезу селективного інгібітора щодо протеїнкінази, і способи їх отримання
JP6332818B2 (ja) チカグレロルの中間体およびその製造法、およびチカグレロルの製造法
JP5524221B2 (ja) 合成中間体としてのチアゾリル−ピラゾロピリミジン化合物および関連合成方法
JP2005535672A (ja) 9−[4−アセトキシ−3−(アセトキシメチル)ブタ−1−イル]−2−アミノプリンの製造方法
JP2009503034A (ja) 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法
JP2012509267A5 (ja) (R)−3−(2,3−ジヒドロキシプロピル)−6−フルオロ−5−(2−フルオロ−4−ヨードフェニルアミノ)−8−メチルピリド[2,3−d]ピリミジン−4,7(3H,8H)−ジオンを製造するためのプロセス及びその中間体
JPH0613477B2 (ja) 5−ヒドラジノ−1h−ピラゾ−ル系化合物
JP2010508334A (ja) アミノベンゾシクロヘプテン誘導体、その調製方法及び治療におけるその使用
CN113816955B (zh) 一种ret激酶抑制剂中间体及其制备方法
JP4278316B2 (ja) ヒドラジン誘導体の製造方法
JPWO2001062769A1 (ja) インドロピロロカルバゾール誘導体の製造法、その製造中間体及びその製造法
CN120112512A (zh) 制备(z)-3-(2-(5-溴-1h-吲哚-3-基)-2-氰基乙烯基)-4-甲氧基苯甲腈的方法
JP5192807B2 (ja) シュードウリジン保護体の安定結晶
KR20250174969A (ko) 올리고뉴클레오티드 유사체 또는 이의 염을 제조하기 위한 중간체 및 이의 제조 방법
WO2024093091A1 (zh) 一种海鞘素类化合物中间体的制备方法
JP2001226394A (ja) 2’−デオキシ−β−グアノシンの製造法およびその中間体
BR112020001396B1 (pt) Intermediários úteis na síntese de derivados de aminopirimidina, processo para preparar os mesmos e processo para preparar derivados de aminopirimidina usando os mesmos
JPS62192361A (ja) ピラゾ−ル類とその製法
JPWO2001044251A1 (ja) 光学活性ピロロアゼピン誘導体の製造方法

Legal Events

Date Code Title Description
FZDE Discontinued